Oral Pemphigus treated with minipulse therapy.

  • Kundoor Vinay Kumar Reddy Dept. of Oral Medicine and Radiology, Mamata Dental College and Hospital, Khammam, Telangana,
  • Kotya Naik Maloth Dept. of Oral Medicine and Radiology, Mamata Dental College and Hospital, Khammam, Telangana,
  • Tejaswini Meesala Dept. of Oral Medicine and Radiology, Mamata Dental College and Hospital, Khammam, Telangana,
  • Moni Thakur Dept. of oral and maxillofacial pathology, Mamata dental college, Khammam, Telangana,

Abstract

Pemphigus is a chronic potentially fatal autoimmune disorder that causes blisters and erosions of the skin and oral mucous membrane. Most of the cases present oral manifestations as the first clinical sign along with dermal lesions. Only 0.5 to 3.2 of cases are reported each year per 1,000,000 population with oral manifestations without dermal participation, and is at times difficult to diagnose. We report a case of oral pemphigus vulgaris in a 20 year old female patient without dermal manifestations treated with oral mini pulse therapy. Pénfigo oral tratado con terapia minipulse.Resumen: El pénfigo es un trastorno autoinmune crónico potencialmente fatal que causa ampollas y erosiones de la piel y la membrana mucosa oral. La mayoría de los casos presentan manifestaciones orales como el primer signo clínico junto con lesiones dérmicas. Solo se reportan de 0.5 a 3.2 casos cada año por cada 1,000,000 de personas con manifestaciones orales sin afectación de la piel, y algunas veces es difícil de diagnosticar. Presentamos un caso de pénfigo vulgar oral en un paciente de 20 años, sin manifestaciones cutáneas tratadas con mini terapia del pulso oral.

Author Biography

Kundoor Vinay Kumar Reddy, Dept. of Oral Medicine and Radiology, Mamata Dental College and Hospital, Khammam, Telangana,
Interim Editor -in- Chief

References

1. Arpita R, Monica A, Venkatesh N, Atul S, Varun M. Oral Pemphigus Vulgaris: Case Report. Ethiop J Health Sci. 2015;25(4):367–72.
2. Shamim T, Varghese V, Shameena PM, Sudha S. Pemphigus vulgaris in oral cavity: clinical analysis of 71 cases. Med Oral Patol Oral Cir Bucal. 2008;13(10):E622–6.
3. Williams DM. Vesiculobullous mucocutaneous disease: pemphigus vulgaris. J Oral Pathol Med. 1989;18(10):544–53.
4. Scully C, Paes De Almeida O, Porter SR, Gilkes JJ. Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol. 1999;140(1):84–9.
5. DiMarco C. Pemphigus: Pathogenesis to Treatment. R I Med J. 2016;99(12):28–31.
6. Dagistan S, Goregen M, Miloglu O, Cakur B. Oral pemphigus vulgaris: a case report with review of the literature. J Oral Sci. 2008;50(3):359–62.
7. Di Zenzo G, Amber KT, Sayar BS, Müller EJ, Borradori L. Immune response in pemphigus and beyond: progresses and emerging concepts. Semin Immunopathol. 2016;38(1):57–74.
8. Urbano FL. Nikolsky's Sign in Autoimmune Skin Disorders. Hospital Physician. 2001:23–4.
9. Hertl M, Jedlickova H, Karpati S, Marinovic B, Uzun S, Yayli S, Mimouni D, Borradori L, Feliciani C, Ioannides D, Joly P, Kowalewski C, Zambruno G, Zillikens D, Jonkman MF. Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2015;29(3):405–14.
10. Harman KE, Albert S, Black MM, British Association of Dermatologists. Guidelines for the management of pemphigus vulgaris. Br J Dermatol. 2003;149(5):926–37.
11. Thorn GW, Forsham PH, Frawley TF, Hill SR Jr, Roche M, Staehelin D, Wilson DL. The clinical usefulness of ACTH and cortisone. N Engl J Med. 1950;242(22):865–72.
12. Costello MJ, Jaimovich L, Dannenberg M. Treatment of pemphigus with corticosteroids; study of fifty-two patients. J Am Med Assoc. 1957;165(10):1249–55.
13. Lever WF, White H. Treatment of pemphigus with corticosteroids: Results obtained in 46 patients over a period of 11 years. Arch Dermatol. 1963;87:52–66.
14. Bystryn JC. Adjuvant therapy of pemphigus. Arch Dermatol. 1984;120(7):941–51.
15. Kaul R, Sanjay CJ. Review on Pulse Therapy: A Novel Approach in the Treatment of Pemphigus Vulgaris. J Indian Acad Oral Med Radiol. 2010;22(4):211–4.
16. Maloth KN, Sunitha K, Boyapati R, Kumar DRS. Bullous Lichen Planus treated with Oral Minipulse Therapy: A Rare Case Report. J Clin Diagn Res. 2014;8(12):ZD17–9.
17. Kauntz SL, Cohn R. Initial treatment of renal allografts with large intra renal doses of immunosuppressive drugs. Lancet. 1969;293:338–40.
18. Pasricha JS, Gupta R. Pulse therapy with dexametha-sonecyclophosphamide in pemphigus. Indian J Dermatol Venereol Leprol. 1984;50:199–203.
19. Malhotra AK, Khaitan BK, Sethuraman G, Sharma VK. Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: A randomized comparative study. J Am Acad Dermatol. 2008;58(4):596–602.
20. Fellner MJ, Sapadin AN. Current therapy of pemphigus vulgaris. Mt Sinai J Med. 2001;68(4-5):268–78.
Published
2018-12-18
How to Cite
REDDY, Kundoor Vinay Kumar et al. Oral Pemphigus treated with minipulse therapy.. Journal of Oral Research, [S.l.], v. 7, n. 9, p. 368-372, dec. 2018. ISSN 0719-2479. Available at: <http://joralres.com/index.php/JOR/article/view/joralres.2018.087>. Date accessed: 25 may 2019. doi: https://doi.org/10.17126/joralres.2018.087.

Keywords

autoimmune diseases, blister, pulse therapy, pemphigus. Enfermedades autoinmunes; ampolla, terapia de pulso; pénfigo